Peripheral T-cell lymphona following diffuse large B-cell lymphoma associated with celiac disease

Internal Medicine

Volumn 47, Issue 4, 2008, Pages 295-298

  Makishima, Hideki ^a   Komiyama, Yuichi ^b   Asano, Naoko ^c   Momose, Kayoko ^a   Nakamura, Shigeo ^c   Ishida, Fumihiro ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Specified Medical Corporation Jisenkai Aizawa Hospital   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Celiac disease; Celiac disease associated lymphoma; Peripheral T cell lymphoma

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR4; CYCLOPHOSPHAMIDE; DOXORUBICIN; GLUTEN; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

AGED; ARTICLE; AUTOPSY; B CELL LYMPHOMA; CANCER MORTALITY; CANCER RECURRENCE; CASE REPORT; CELIAC DISEASE; DIARRHEA; DISEASE ASSOCIATION; DUODENUM BIOPSY; EDEMA; FOOD COMPOSITION; GASTROINTESTINAL SYMPTOM; GLUTEN FREE DIET; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; HYPOXEMIA; JAPANESE; LYMPHADENOPATHY; MALE; MULTIPLE CYCLE TREATMENT; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PLEURA EFFUSION; PROTEIN EXPRESSION; RISK FACTOR; T CELL LYMPHOMA; THORACOCENTESIS; TUMOR BIOPSY;

AGED; CELIAC DISEASE; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, T-CELL, PERIPHERAL; MALE;

EID: 40749088450     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0500     Document Type: Article

References (26)

1. Green PH, Jabri B. Coeliac disease. Lancet 362: 383-391, 2003.
2. Kagnoff MF. Overview and pathogenesis of celiac disease. Gastroenterology 128: S10-18, 2005.
3. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 346: 180-188, 2002.
4. Makishima H, Ito T, Kodama R, et al. Intestinal diffuse large B-cell lymphoma associated with celiac disease: a Japanese case. Int J Hematol 83: 63-65, 2006.
5. Catassi C, Bearzi I, Holmes GK. Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology 128: S 79-86, 2005.
6. Rueffer U, Josting A, Franklin J, et al. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis. J Clin Oncol 19: 2026-2032, 2001.
7. Kau HC, Ho HC, Kao SC, Yang CF, Hsu WM, Tsai CC. T-cell lymphoma in the eyelid following intestinal B-cell lymphoma. Eye 16: 794-796, 2002.
8. Micallef IN, Kirk A, Norton A, Foran JM, Rohatiner AZ, Lister TA. Peripheral T-cell lymphoma following rituximab therapy for B-cell lymphoma. Blood 93: 2427-2428, 1999.
9. Holmes GK, Prior P, Lane MR, Pope D, Allan RN. Malignancy in coeliac disease - effect of a gluten free diet. Gut 30: 333-338, 1989.
10. Nava VE, Cohen P, Bishop M, Fowler D, Jaffe ES, Ozdemirli M. Enteropathy-type T-cell lymphoma after intestinal diffuse large B-cell lymphoma. Am J Surg Pathol 31: 476-480, 2007.
11. Oita T, Yamashiro A, Mizutani F, Tamura A, Sakizono K, Okada A. Simultaneous presence of macroamylase and macrolipase in patient with celiac disease. Rinsho Byori 51: 974-977, 2003.
12. Ihara M, Makino F, Sawada H, et al. Gluten sensitivity in Japanese patients with adult-onset cerebellar ataxia. Intern Med 45: 135-140, 2006.
13. Amo Y, Tanei R, Tanabe K, Katsuoka K. Dermatitis herpetiformis in a Japanese patient with anaplastic large cell lymphoma. J Dermatol 27: 533-536, 2000.
14. Freeman HJ. Biopsy-defined adult celiac disease in Asian-Canadians. Can J Gastroenterol 17: 433-436, 2003.
15. Catassi C, Fabiani E, Corrao G, et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 287: 1413-1419, 2002.
16. Isaacson PG, Wright DH, Ralfkiaer E, Jaffe ES. Enteropathy-type T-cell lymphoma. In: World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Jaffe ES, Harris NL, Stein H, Vardiman JW, Eds. IARC Press, Lyon, 2001: 208-209.
17. Green PH, Fleischauer AT, Bhagat G, Goyal R, Jabri B, Neugut AI. Risk of malignancy in patients with celiac disease. Am J Med 115: 191-195, 2003.
18. Card TR, West J, Holmes GK. Risk of malignancy in diagnosed coeliac disease:a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther 20: 769-775, 2004.
19. Smedby KE, Akerman M, Hildebrand H, Glimelius B, Ekbom A, Askling J. Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut 54: 54-59, 2005.
20. Ishida T, Inagaki H, Utsunomiya A, et al. CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified. Clin Cancer Res 10: 5494-5500, 2004.
21. Makishima H, Ito T, Asano N, et al. Significance of chemokine receptor expression in aggressive NK cell leukemia. Leukemia 19: 1169-1174, 2005.
22. Ohshima K, Karube K, Kawano R, et al. Classification of distinct subtypes of peripheral T-cell lymphoma unspecified, identified by chemokine and chemokine receptor expression: Analysis of prognosis. Int J Oncol 25: 605-613, 2004.
23. Ishida T, Utsunomiya A, Iida S, et al. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome. Clin Cancer Res 9: 3625-3634, 2003.
24. Atanackovic D, Block A, de Weerth A, Faltz C, Hossfeld DK, Hegewisch-Becker S. Characterization of effusion-infiltrating T cells: benign versus malignant effusions. Clin Cancer Res 10: 2600-2608, 2004.
25. Asano N, Suzuki R, Kagami Y, et al. Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified. Am J Surg Pathol 29: 1284-1293, 2005.
26. Collin P, Reunala T, Pukkala E, Laippala P, Keyrilainen O, Pasternack A. Coeliac disease - associated disorders and survival. Gut 35: 1215-1218, 1994.